Skip to main content

FDA Approvals

First-Line Mosunetuzumab Safe and Effective in Older Patients with Diffuse Large B-Cell Lymphoma

Chase Doyle

FDA Approves Tepmetko for Metastatic NSCLC and MET Exon 14 Skipping Alterations

FDA Approves Margenza for Treatment of Metastatic HER2-Positive Breast Cancer

Orgovyx First FDA-Approved Oral Hormone Therapy for Advanced Prostate Cancer

Keytruda plus Chemotherapy Approved for Unresectable or Metastatic Triple‑Negative Breast Cancer

Opdivo plus Yervoy First Immunotherapy Approved for Unresectable Malignant Pleural Mesothelioma

FDA Approves First Prostate-Specific Membrane Antigen–Targeted PET Imaging Drug for Prostate Cancer

FDA Approvals, Leukemia, Oncology

Oral Onureg First Drug Approved for Adults with AML in Remission

Danyelza Receives FDA Approval for High-Risk Neuroblastoma in the Bone and Bone Marrow

Gavreto, a New RET Inhibitor, Now Approved for Thyroid Cancer with RET Fusions

Page 14 of 53
Results 131 - 140 of 522